Risk Factors Associated with Infusion Reactions to Infliximab in Chinese Patients with Inflammatory Bowel Disease: A Large Single-Center Study

BACKGROUND: This study investigated the risk factors of infliximab (IFX)-related infusion reactions (IR) in Chinese patients with inflammatory bowel disease (IBD). MATERIAL/METHODS: The medical records of 330 consecutive IBD patients treated with IFX between 2009 and 2017 were reviewed. The incidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaolei, Cao, Jingli, Wang, Haichao, Ye, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448455/
https://www.ncbi.nlm.nih.gov/pubmed/30917108
http://dx.doi.org/10.12659/MSM.913152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448455/
https://www.ncbi.nlm.nih.gov/pubmed/30917108
http://dx.doi.org/10.12659/MSM.913152

Ejemplares similares